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Specialized d e n d r i t i c cells (DC) 1 have been identified in l y m p h o i d organs o f mouse
a n d rat (1-3). In all tissues, the frequency o f D C is < 1 % of n u c l e a t e d cells, as
c o n f i r m e d using a m o n o c l o n a l a n t i b o d y (Ab) specific for mouse D C (4). M e t h o d s for
e n r i c h i n g D C are a v a i l a b l e (2, 3, 5). As a result, several distinctive functions of D C
have been established. D C are p o t e n t stimulators o f m i x e d leukocyte reactions ( M L R )
(3, 6-8) a n d accessory cells for several i m m u n e responses (2, 9-11). Recently, it has
been shown t h a t selective e l i m i n a t i o n of D C with m o n o c l o n a l cytotoxic A b a n d
c o m p l e m e n t ablates M L R - s t i m u l a t i n g c a p a c i t y a n d accessory function in mouse
spleen a n d s p l e e n - a d h e r e n t cells (12). T h e study of i m m u n e responses in m a n requires
t h a t the e q u i v a l e n t o f the r o d e n t D C be identified.
W e have chosen p e r i p h e r a l b l o o d m o n o n u c l e a r cells (PBMC) to begin the characterization o f h u m a n D C for several reasons. Large n u m b e r s of b l o o d leukocytes are
readily o b t a i n e d from b l o o d - b a n k i n g facilities, m a k i n g it possible to enrich for a trace
cell t y p e like the DC. I f the functional d a t a on rodents are a p p l i c a b l e to m a n , then
D C should be present in P B M C , which are active M L R stimulators a n d proliferate
when m o d i f i e d by oxidizing agents. O n e w o u l d also predict that some stage of the
D C lineage w o u l d be present in the circulation, because D C are b o n e m a r r o w - d e r i v e d
a n d u n d e r g o r a p i d t u r n o v e r in mouse spleen (13).
W e show here t h a t 0.1-0.5% of h u m a n P B M C have the same cytologic features as
r o d e n t DC. E n r i c h e d (20-60%) p o p u l a t i o n s o f D C can be o b t a i n e d with an a p p r o a c h
m o d e l e d after the techniques used to purify mouse DC. H u m a n D C are Ia positive
a n d lack surface Ig, Fc receptors, the receptor for sheep erythrocytes, a n d several new
l y m p h o c y t e a n d m o n o c y t e antigens defined by m o n o c l o n a l Ab. F u n c t i o n a l studies
indicate t h a t h u m a n D C are 10-30 times more active t h a n other leukocytes as M L R
stimulators a n d as accessory cells for oxidative mitogenesis.
Materials and Methods
Culture Media and Serum. Cells were cultured in RPMI 1640 (Gibco Laboratories, Grand Island
Biological Co., Grand Island, NY) supplemented with 1 mM gtutamine (Gibco Laboratories),
* Supported by grants CA 30198 and AI 13013 from the National Institutes of Health.
:~Established Investigator of the American Heart Association.
i Abbreviations used in this paper: Ab, antibody; BPA, bovine plasma albumin; DC, dendritic cells, E,
erythrocyte; EA, sheep E coated with anti-sheep E Ab; EAET,sheep E modified with 2-aminoethylisothiouronium bromide; EIgM, sheep E coated with anti-sheep E IgM Ab; EIgMC, sheep E coated with antisheep E IgM Ab and complement; EM, electron microscopy; E,, sheep E modified with neuraminidase;
FCS, fetal calf serum; HRP, horseradish peroxidase; MLR, mixed leukocyte reaction; NBCS, newborn calf
serum; PBMC, peripheral blood mononuclear cells; PBS, phosphate-buffered saline; PLL, poly-lAysine.
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5 × 10-5 M 2-mercaptoethanol (Eastman Kodak, Rochester, NY), 100 U / m l penicillin, 20/lg/
ml gentamycin (Schering Corp., Kenilworth, NJ), and 5-10% serum. Fetal calf serum (FCS;
Flow Laboratories, Inc., Rockville, MD) and newborn calf serum (NBCS; North American
Biologicals, Miami, FL) were heat inactivated at 56°C for 30 min. Human serum was prepared
from 1 U of whole A + blood with no additives (Greater New York Blood Center, New York)
after 4 h of clotting at 4°C, clarification by centrifugation, and storage at -70°C.
Microscopy, Staining, and Cytochemist~y. To examine cells in suspension by light microscopy,
we centrifuged (400 g, 10 min, room temperature) 2 × 105 cells onto 12-mm circular cover slips
(Propper Manufacturing Co., Long Island City, NY, CGS, distributed by SGA Scientific,
Bloomfield, N J) coated with 75 ~g/ml poly-L-lysine (PLL, type VII, Sigma Chemical Co., St.
Louis, MO), and incubated the cover slips for 20 min in RPMI 1640 to allow spreading. For
phase contrast, cells were fixed with 1.25% glutaraldehyde in phosphate-buffered saline (PBS)
for 15-30 rain. To make lysosomes visible, cells were exposed to acridine orange (Allied
Chemical Corp., Morristown, N J), 2.5 ~g/ml culture medium at 37°C for 20 min, rinsed, and
mounted in medium for immediate viewing with a fluorescent microscope as described (14).
Giemsa (10% in PBS, Fisher Scientific Co., Pittsburgh, PA) staining was for 10-20 min on
cytocentrifuged specimens fixed 10 min in absolute methanol. Endogenous myeloperoxidase
and exogenous horseradish peroxidase (type II, Sigma Chemical Co.) were visualized in
glutaraldehyde-fixed cells exposed to 0.4 mg/ml 3,3'diaminobenzidine tetrahydrochloride
(grade II, Sigma Chemical Co.) and 0.1% hydrogen peroxide (Mallinckrodt Inc., St. Louis,
MO) in 0.1 M tris, pH 7.5, for 10 rain at 20°C. Nonspeeifie esterase staining with alphanaphthyl-butyrate (Sigma Chemical Co.) was exactly according to Li et al. (15).
For transmission electron microscopy (EM), cells were fixed in a mixture of 1.25% glutaraldehyde and 1% osmium tetroxide, stained en bloc with 0.25% uranyl acetate, and embedded in
Epon as described (1). For scanning EM, cells on cover slips were fixed in 1.25% glutaraldehyde/
PBS, washed, and stored in 0.1 M sucrose in 0.1 osmium cacodylate pH 7.4. Just before
examination, the cover slips were dehydrated in ethanol, transferred to amyl acetate, and
critical-point dried (Hitachi CTI, Tokyo, Japan) in CO2. Specimens were coated with gold
(Polaron EM coating unit, E5000, Polaron Instruments Inc., Doylestown, PA) and examined
with a high resolution Hitachi scanning electron microscope (HHS/2R) at 20 kv, at a tilt angle
of 30 ° (16).
Endocytic Tests. Soluble horseradish peroxidase was used as a marker for pinocytosis as
described (17). Zymosan (Sigma Chemical Co.) and latex (1.1 /ira, The Dow Chemical Co.,
Indianapolis, IN) were used to monitor phagoeytosis at particle/cell ratios of 20:1 and 200:1,
respectively, for 1 h at 37°C.
Indicator EoJthrocytes (E): Sheep erythroeytes (Scott Labs, FiskeviUe, RI) and bovine erythrocytes (Rockland Inc., Gilbertsville, PA) were obtained in alsevers and used within 2 wk of
arrival. For E rosetting, washed sheep E at 5% vol/vol in RPMI 1640 were treated with 0.02 U
of Vibrio cholerae neuraminidase (En) (Calbiochem-Behring Corp., LaJolla, CA) per ml at 37°C
for 45 min and washed three times (18); alternatively, washed sheep E were treated with 2
aminoethylisothiouronium bromide (EAET) (Calbiochem-Behring Corp.) exactly by the method
of Kaplan et al. (19). Both En and EAET rosetted >80% of nonadherent PBMC, but <5% of B
cell-enriched fractions. Sheep E coated with antibody (EA), IgM (EIgM), and IgM plus mouse
complement (EIgMC) were prepared as described (5). E-anti-human Ig were prepared using
saline-washed bovine E and chromic chloride coupling (20). Rabbit anti-human F(ab)'2 IgG
fragment serum was affinity purified on human IgG linked to cyanogen bromide-activated
Sepharose 4B (Pharmaeia Fine Chemicals, Div. Pharmaeia Inc., Piscataway, NJ). E antihuman Ig bound >80% of B cell and <5% o f T cell-enriched fractions. Rosettes were formed in
suspension (50 indicator cells per leucocyte were spun into a pellet) or on monolayers (1 × 107
to 2 × 107 indicator cells were spun onto 12-mm cover slips in 13-mm glass cylinders).
Immunofluorescence. All reagents for immunofluorescence were diluted in 5% NBCS-RPMI
1640-0.02% sodium azide. Two heteroantisera were directly labeled with fluorochrome: rhodamine-coupled F(ab)'2 goat anti-human IgG, IgM, and IgD (N. L. Cappel Laboratories,
Cochranville, PA), and rhodamine-coupled F(ab)'~ rabbit anti-human glycoprotein 29/33 (antiHLA-DR [21], a generous gift of Dr. Shu Man Fu of The Rockefeller University). A large
group of mouse monoclonal Ab were visualized by indirect immunofluoresence: anti-HLA
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(61D2 [22], 1 t~g/ml, Bethesda Research Laboratories, Rockville, MD), anti-HLA-DR (59.5, 1
~g/ml; and OKIal [23], 1/40 of ascites, Ortho Pharmaceutical, Raritan, NJ); antimonocyte
(63D3, 10/.tg/ml; 61D3 [22], 1/Lg/ml BRL; OKMI [24], 50 #g/ml, Ortbo Pharmaceutical; and
MI/70, rat anti-mouse "Mac-l" [25], culture supernatant kindly supplied by Dr. T. Springer,
Harvard University, Boston, MA); anti-Fc receptor (clone 3G8 [26], 30 ~tg/ml, kindly provided
by Dr. J. Unkeless and Dr. H. Fleit of The Rockefeller University); anti-leukocyte common
antigen (T29/33 [27], 1:300 dilution of ascites kindly supplied by Dr. I. S. Trowbridge, Salk
Institute, La Jolla, CA); anti-human T cells (OKT 3 [28, 29], pan T cell Ag, 0.6/.tg/ml; OKT6
[29, 30], common thymocyte and Langerhans cell Ag, 1.2/*g/ml; OKT8, I28, 29], suppressor
cytotoxic Ag, 50 ~g/ml, Ortho Pharmaceutical). Cells on PLL~coated cover slips were exposed
to the primary Ab for 60 min at 4°C, rinsed in PBS, exposed to biotinylated horse anti-mouse
IgG (Vector Laboratories, Burlingame, CA) at 50 btg/ml for 30 rain at 4°C, rinsed in PBS, and
overlaid with fluoresceinated avidin (Vector Laboratories) at 100 ~g/ml for 30 min at 4°C,
rinsed, fixed in 10% formalin/PBS for 20 min, mounted in glycerol, and viewed by epifluorescence (Zeiss photomicroscope II, Carl Zeiss, Inc., New York). To detect intracellular Ig, ceils on
PLL-coated cover slips were formalin fixed, rinsed in PBS, exposed to absolute methanol for 30
s, rinsed in PBS, and treated with rhodamine anti-human Ig, as above. This technique detects
intracellular Ig in plasma cells from tonsil.
Enriched Populations of T Cells, Monocytes, B Cells, and DC (Table It). Our starting population
was a concentrated leukocyte fraction (buffycoat) derived from 400 ml of blood by the Greater
New York Blood Center. PBMC were recovered on Ficoll 400/sodium diatrizoate (Histopaque
1.077, Sigma Chemical Co,) with a yield after three washes of 4 X 108 to 10 X l0s mononuclear
cells per buffycoat. Leukocyte subpopulations were identified by standard cytologic and surface
markers as described in results.
5 × 107 PBMC were plated in 5% FCS medium on 100-mm plastic tissue culture plates
(Falcon 3003, Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, CA) for 1 h at 37°C.
Nonadherent cells were removed with five rinses of RPMI 1640 and used as a source of T cells.
The T cells were purified on nylon wool according to Julius et al. (31). 10 × 107 to 20 × 107
nonadherent PBMC in 10% NBCS medium were loaded onto 3 g of nylon wool (Leukopak,
Fenwal Lab, Division of Travenol, Deerfield, IL) in a 30-cc disposable plastic syringe, incubated
at 37°C for 45 rain, eluted dropwise over 15 rain, and washed three times in RPMI 1640 before
use. The population was >97% T cells, <3% monocytes, and <1% DC. Alternatively, nonadherent PBMC were separated into E rosette positive and negative fractions after rosetting with
a 50:l ratio of En to PBMC and centrifugation on Ficoll/diatrizoate (17). E, were lysed in
ammonium chloride and the fractions washed three times before use. The E + fraction was
>90% T cells, <10% monocytes, and <1% DC. The E- or non-T cell fraction was <20% T celts,
30-50% Ig-positive cells, 8-30% monocytes, and 2-10% DC.
Adherent PBMC were incubated for 16 h at 37°C in 5% FCS medium. About one-half the
cells had released from the plates (released once) and were reattached in fresh medium to
another 100-ram plastic plate for 1 h. The populations that adhered after overnight culture, or
after the readherence step, were highly enriched in monocytes (80-90%) and had some small
lymphocytes (5-15%) and DC (1-6%). Monocytes were eluted from the plates after treatment
with phosphate saline supplemented with 10 mM ethylenediaminetetraacetic acid (Fisher
Scientific Co., Pittsburgh, PA), pH 7.4, for 30 rain at 4°C, or were dislodged by vigorous
pipetting.
Cells that did not readhere (released twice) after overnight culture were used as a source of
enriched B cells and DC. The population was either rosetted with E anti-human Ig (50:1 ratio
ofE anti-Ig/PBMC; 4°C, 20 min) or floated directly in bovine plasma albumin (BPA; Armour
Pharmaceutical, Chicago, IL). 2 × 107 to 4 × 10 7 cells ( + / - rosettes) were resuspended in 4 ml
BPA, d = t.082, and overlaid with BPA at 1.047 (2 hal). The columns were centrifuged at
10,000 g for 15 min at 4°C, to provide low density (1.047:1.080) interface and high density
(pellet) fractions that were harvested and washed 3 times in RPMI 1640. The low density
population could be additionally depleted of monocytes by a final adherence on plastic. The
low density fraction (2 × 106 to 5 × 106 cells/buffycoat) contained 20-60% DC, 10-25%
monocytes, and the balance small cells. If the fractionation included E anti-Ig rosetting, <1'7c
of the low density cells had surface Ig, even after 4 d of additional culture. Without rosetting,
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TABLE I
Enrichment Procedurefor Dendritic Cells in Human Blood
Concentrated leukocyte fraction
(buffy coat)
Granulocytes ~,
erythrocytes

Cell yield
(percent of
starting)

PercentDC

100

<1

20

1-2

11

2-4

6

3-6

l Ficoll-Diatrizoate

Nonadherent PBMC (

Adherence

E, rosetting
or nylon wool
T cell enriched
Adherent PBMC
Firmly adherent,
monocyte enriched

Culture
16 h
Released 1 ×

Readherent,
monocyte enriched

I Readhere

Released 2 X
High density, released 2 × (
B cell enriched

Readherent, released 2 X (

Flotation
in dense BPA;
+ / - rosetting
E a-human Ig
Low density, released 2 x

0.8

10-30

Low de~nsity,released 3 ×
DC enriched

0.5

20-60

!

20-40% of the low density population was Ig positive cells. The high density fraction was always
>80% Ig positive cells with small numbers of monocytes (2-5%) and DC (1-4%). DC in the
high density fraction would not float if centrifuged in an additional BPA column.
Functional Assays. Functional assays were done in triplicate microtest wells with 1.5 × 10'~
responder T-enriched lymphocytes per flat-bottomed well (Costar, Data Packaging, Cambridge,
MA) in 200 ~1 culture medium, or in round-bottomed wells (Linbro Chemical Co., Hamden,
CT) in 150/zl medium. A+ leukocytes and 10% A+ human serum were used. T cells were
prepared from nonadherent PBMC by En rosetting, or passage over nylon wool, as described
above. For MLR assays, stimulator cells were irradiated with 3,000 rad (Cslay, Gamma cell
1000, Atomic Energy of Canada, Ottawa, Canada). For oxidative mitogenesis, the accessory
cells were irradiated, and the T cells were modified with 2 mM sodium periodate (Sigma
Chemical Co.) in PBS for 30 rain at 0°C, followed by washing. Proliferation by unmodified
(not periodate-treated) controls was <10% of periodate-treated samples. Proliferation was
measured with 1 ~Ci [3H]thymidine in 50/~l/well (Schwarz/Mann Div., Becton, Dickinson &
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Co., Orangeburg, NY, 6 Ci/mM) at 104-120 h (MLR) and 56-72 h (periodate). Cells were
harvested in a multisample harvester, and the data displayed as mean counts per minute ___
standard deviation of the mean.
Results

Fro. 1. Phase-contrast microscopy of glutaraldehyde-fixed, adherent mononuclear cells (× 1,080).
(a) Fresh mononuclear cells adherent to glass. A DO is surrounded by four monocytes, which exhibit
typical ruffles, lysosomes, and pinocytic vesicles. (b, c) DO from DC-enriched fractions, after
attachment and spreading on PLL-coated glass cover slips. Dendrites extend in several directions,
and the cytoplasm is full of granules that are mitochondria. At the top of Fig 1 c is a typical small
lymphocyte, which does not have processesor ruffles when attached to PLL. (d) Monocytes adherent
to PLL-coated glass. The cells spread more actively than on non-PLL-coated glass or plastic, and
the characteristic ruffles and organelles are more readily visualized.
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A small p e r c e n t a g e (1-2%) of a d h e r e n t h u m a n P B M C h a d similar m o r p h o l o g i c
features to the D C isolated from mouse l y m p h o i d organs (1). These features included:
irregular shape, a b u n d a n t phase-dense granules (mitochondria), irregular nucleus
with small nucleoli, a n d a p r o m i n e n t rim o f h e t e r o c h r o m a t i n . T h e r e were few surface
ruffles, p i n o c y t i c vesicles, or lysosomes, organelles that were a b u n d a n t in a d j a c e n t
monocytes (Fig. 1 a). W e first devised a m u l t i s t e p p r o c e d u r e for e n r i c h i n g these
" c a n d i d a t e " DC. This involved successive d e p l e t i o n o f T cells, monocytes, a n d B cells.
W e could then show t h a t the cytologic, surface, a n d functional properties o f h u m a n
D C were similar to their c o u n t e r p a r t s in rodents.
Enriched Preparations of Human DC. T h e p u r i f i c a t i o n o f h u m a n D C was m o n i t o r e d
b y phase-contrast microscopy o f specimens fixed in g l u t a r a l d e h y d e . At each stage o f
the protocol ( T a b l e I), samples were a t t a c h e d to P L L - c o a t e d cover slips a n d i n c u b a t e d
at 37°C to allow cells to spread. D C e x h i b i t e d m a n y processes, m i t o c h o n d r i a , a n d
irregular nuclei (Fig. 1 b, c). M o n o c y t e s s p r e a d c i r c u m f e r e n t i a l l y a n d h a d clear ruffles,
p i n o c y t i c vesicles, lysosomes, a n d oval- or k i d n e y - s h a p e d nuclei (Fig. 1 d). Small
l y m p h o c y t e s showed little s p r e a d i n g (Fig. 1 c), except in the case o f B cells, which
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could form cell processes when attached to anti-Ig-coated erythrocytes. Subsequent
studies with cell surface markers confirmed that these cytologic criteria were appropriate for differentiating DC, monocytes, and lymphocytes (see below).
DC enrichment required several steps and stimultaneously provided populations
that were predominately monocytes, B cells, or T cells (Table I). Mononuclear cells
(<1% DC) were obtained from Ficoll-Diatrizoate columns and attached to plastic.
The adherent population contained 70-90% monocytes, 5-15% lymphocytes, and
<5% DC. The nonadherent fraction contained most of the T cells and small percentages of monocytes (<5%), B cells (5-10%), and DC (< 1-2%). The adherent population
was cultured overnight and the once-released cells reattached to plastic. This provided
an adherent fraction rich in monocytes and a nonadherent (twice-released) fraction
containing B cells, most of the DC, and variable percentages (10-40%) of monocytes.
The twice-released cells were then floated on dense BPA columns to obtain a high
density B lymphocyte fraction and a low density population enriched in DC. Further
enrichment of DC could be obtained by depleting B cells with E anti-Ig and by
additional adherence to monocytes to plastic.
This procedure reproducibly provided populations that were 20-60% DC, so that
a > 100-fold enrichment over PBMC had been obtained. The principle contaminating
cells were monocytes (10-20%) and small cells of uncertain type that lacked B and T
lymphocyte markers. Attempts to further purify DC led to unacceptable losses. We
also analyzed specimens obtained from fresh venipuncture, rather than buffycoat. In
10 samples from 8 donors, we obtained a yield of low density, once-released DC
corresponding to 0.3 + 0.2% of total PBMC.
Staining Techniques and Electron Microscopy. DC-enriched fractions were compared
with other cell types using several cytologic techniques. On Giemsa stain, the DC
cytoplasm was a pale blue-gray, like monocytes, and lacked azurophilic granules.
Both DC and lymphocytes had small numbers of lysosomes, detected by acridine
orange staining, whereas all monocytes had abundant granular staining. DC and
lymphocytes were peroxidase negative, whereas >80-90% of monocytes had typical
peroxidase-positive granules. Finally, DC and lymphocytes were esterase negative, or
had weak staining in the perinuclear region, while >80% of monocytes were strongly
positive.
By transmission EM (Fig. 2 a), the DC-enriched fraction contained small cells
(-50%) with the features of lymphocytes, a minor component (<20%) of typical
monocytes with many lysosomes and surface ruffles, and cells (25-40%) resembling
mouse DC (Fig. 2 a). The nuclei of presumptive DC were irregular in shape, with a
thick rim of heterochromatin and small nucleoli. The surface was irregular incontour
but lacked the discrete microvilli and ruffles seen on lymphocytes and monocytes.
Mitochondria were numerous, but rough endoplasmic reticulum, free polysomes and
ribosomes, and lysosomes were scanty. Multivesicular bodies and chains of small,
smooth vesicles were noted. Birbeck granules, which are found in epidermal Langerhans cells, were not detected in either DC- or monocyte-enriched fractions.
By scanning EM (Fig. 2 b, c) 30% of the cells in the DC-enriched population had
similar features to adherent mouse DC. When attached to PLL, the smooth DC
surface formed many dendrites and large lamellipodia. Monocytes were entirely
different in appearance because they spread circumferentially and were covered with
surface folds (Fig. 2 d). We conclude that the DC in human PBMC have similar
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FIc. 2. EM of glutaraldehyde- and o s m i u m - l x e d mononuclear cells. (a) Transmission EM of
presumptive DC fixed in suspension. Cells with similar cytologic features (see text) account for
about one-third of DC-enriehed fractions. × 11,300. (b, c) Scanning EM of DC fixed 20 min after
attachment to PLL-coated cover slips. T h e smooth surface forms m a n y dendrites a n d / o r large
lamellipodia. × 5,900 and 6,300. (d) Scanning EM of monocytes fixed 20 min after attachment to
PLL. The surface is covered with folds, and the cells spread circumferentially, x 1,900.
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TABLE II

Fluorescent Staining of Subpopulations of PBMC
Antibody (antigen)

OKT3 (PAN T cell antigen)
O K M 1 (monocyte/null cell antigen)
OKIal (HLA-DR antigen)
T29/33 (Human leukocyte-common antigen)
aIg (surface Ig)
63D3 (monocyte antigen)
OKT6 (Thymocyte-common antigen and
Langerhans cell antigen)
61D3 (monocyte antigen)
MI/70 (mac-1; granulocyte, monoeyte antigen)

T cell
enriched*

Monocyte
enriched:[:

B cell
enriched§

DC
enriched [[

%

%

%

%

96
5
3
100
<1

8
5
92
100
85
ND¶
<1

11
10
89
100
<1

<1

10
91
92
100
2
87
<1

ND
ND

96
96

ND
ND

9
10

1

9

<1

Data are representative of three or more experiments with each cell type and antibody, and are expressed
as percent positive (fluorescent) of 200 or more total cells counted. Cell populations were prepared as in
Table I and included:
* Nylon wool-purified T cells. Phase-contrast morphology: 98% lymphocytes, 2% monocytes, 1% DC.
~: Firmly adherent cells. Phase-contrast morphology: 87% monocytes, l 1% lymphocytes, 1% DC.
§ Released twice, high density cells. Phase-contrast morphology: 95% lymphocytes, 4% monocytes, 1%
DC.
[I Low density released three times, E anti-human Ig-negative cells. Phase-contrast morphology: 37%
DC, 10% monocytes, 53% small cells.
¶ Not done.
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cytologic features to mouse DC, and can be distinguished from monocytes and
lymphocytes.
Endocytic Capacity and Rosette Assays. DC behaved more like lymphocytes than
monocytes in standard endocytic tests. DC did not phagocytose zymosan particles or
latex, although some sticking of latex to DC (one to three beads per cell) was evident.
In contrast, monocytes actively phagocytosed both particles. DC pinocytosed little or
no horseradish peroxidase (HRP), as assessed by diaminobenzidine cytochemistry,
after exposure to 1 mg/ml of enzyme for 1-2 h. Although monocytes had endogenous
peroxidase activity, addition of exogenous H R P for 1 h at 37°C resulted in dramatically increased granular peroxidase staining, due to active pinocytosis.
DC and monocytes were also compared in rosette assays with appropriately
modified erythrocytes (see Materials and Methods). DC failed to bind En, EAET, E
anti-human Ig, EIgM, and EA. However, 2-10 EIgMC bound to DC identified by
cytologic criteria. Mouse spleen DC failed to bind EIgMC, as previously reported (5).
Monocytes did not bind En, EEAT, and EIgM. 3-5 E anti-human Ig bound to 10-20%
of monocytes. Large numbers of EA and EIgMC rosetted to monocytes. The EA were
also phagocytosed. Thus, human DC have weak endocytic capacities, are Fc receptor,
surface Ig, and sheep erythrocyte receptor negative, but express complement receptors.
Cell Surface Markers--Indirect Immunofluorescence. A large group of Ab, primarily
monoclonals, were used to visualize surface antigens by immunofluorescence, usually
with sensitive biotin-avidin reagents (Table II). All cells expressed the leukocytecommon antigen (clone T29/33) and HLA (clone 61D2). Most of the ceils in the DCenriched fraction were strongly Ia positive using OKIa 1, anti-HLA-DR (clone 59.5),
and an F(ab)'2 rabbit anti-GP 29/33 (20). Ia was found on most B cells, 30-80% of
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monocytes, and few T cells. Several monocyte antigens (clones 63D3, 61D3, O K M 1,
and Mac-l, or M1/70) were detected on all monocytes and few of the cells in the Band r/'-enriched fractions. 10-20% of the DC-enriched population stained with the
monocyte Ab. This corresponded exactly to the percentage of monocytes enumerated
by cytologic features on well-spread, glutaraldehyde-fixed specimens; also, many of
the positive cells in the fluorescent specimens showed cytologic features of monocytes.
A monoclonal anti-Fc receptor reagent, clone 3G8, did not stain cells in the DCenriched fraction, but it is known that this reagent stains neutrophils primarily, and
relatively few monocytes and B cells (25). All B cells stained for surface Ig, but
staining was rare in purified monocytes and DC fractions. Less than 2% of the latter
stained for intracellular Ig as well. T cell-enriched populations contained >95% O K T
3- (pan T) reactive cells, whereas DC, monocytes, and B cells had ~10% O K T 3
positive cells. DC were also O K T 8 negative (not shown). O K T 6, a monoclonal that
reacts with thymocytes and Langerhans cells, did not stain any PBMC. We conclude
that DC are HLA- and HLA-DR-bearing leukocytes that lack many of the known
differentiation antigens of B cells, T cells, and monocytes.
DC in Culture. In two experiments, enriched preparations of DC were maintained
in culture for 4 d. The distinctive cytologic features of DC persisted, and the cells did
not acquire surface Ig. B cells maintained surface Ig in culture, and monocytes
retained their cytologic features. Therefore, DC do not convert into lymphocytes or
monocytes in vitro.
Stimulation of the Primary MLR. DC-enriched fractions were strong stimulators of
both syngeneic and allogeneic primary M L R , and were at least 10 times more efficient
than other cell populations on a per cell basis (Table III; each of the populations has
been tested in three or more additional experiments with similar results to experiment
2). The potency of the DC-enriched fraction was not reduced after B cell depletion
with E anti-human Ig rosetting (Table III, experiment 2). The use of BPA columns
to enrich DC was not itself responsible for the activity of DC as M L R stimulators.
T h a t is, for both allogeneic and syngeneic MLR, the total stimulating activity
recovered from the BPA columns was similar to the activity in the applied tw:,cereleased cells (not shown).
Other cell fractions were evaluated for MLR-stimulating activity. Contaminating
DC in each fraction were enumerated by cytologic criteria. Monocyte fractions were
at least 10 times less active than DC. Typically, the monocyte fractions contained 16% DC and 80-90% monocytes, and the DC populations had 25-40% DC and 1025% monocytes. Therefore, stimulatory capacity correlated with Ia + DC content,
rather than content of Ia + monocytes (as most monocytes are Ia +, e.g., Table II).
Nonadherent, E rosette-negative or non-T cells were 10-30 times less active than DCenriched fractions in M L R stimulation, and again, small numbers of DC (2-10%)
could be identified in this population. High density B cells, obtained from the twicereleased population (Table I) were consistently 30-50 times less active than enriched
DC (Table III). However, increased stimulating capacity was noted when B cells were
sedimented after E anti-Ig rosetting of twice-released cells (Table III, experiment 2).
This was not attributable to rosetting itself, because B cells that were first sedimented
and then rosetted were not stimulatory (not shown). More likely, the stimulating
activity was due to DC trapped during the rosetting procedure, and in fact, 1-3%
nonrosetted DC were observed in the B cell fractions. Lastly, enriched- T cells were
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TABLE III
Stimulating Capacity of Subpopulations of Mononuclear Cellsfor the 1° Syngeneic (Syn) and Allogeneic (Allo)
MLR
Source
of responder
T cells

B cell enriched (high density released without Ealg rosetting)
T cell enriched (En ÷)
Non-T ceils (En)

Experiment 2
DC enriched (with E a l g rosetting)

DG enriched (without Ealg rosetting)
Monocyte enriched (firmly adherent)
Monocyte enriched (readherent)
B cell enriched (high density after
EaIg rosetting)
B cell enriched (high density without E a l g resetting)
T cell enriched (nylon wool illtered)

105

3 × 104

104

3 × 10a

l03

Syn
Allo
Syn
Allo
Syn
Allo
Syn
Allo
Syn
Allo
Syn
Allo

11,983 4- 605
119,506 ± 4,663
1,131 4- 630
31,148 ± 226
1,706 4- 425
38,361 4- 1,038
219 4- 5
2,766 4- 1,143
ND*
ND
6,012 4- 5,413
36,331 ± 2,105

7,119 4- 2,555
105,350 4- 15,849
2,034 ± 1,976
44,232 ± 4,712
762 ± 243
29,937 4- 3,655
526 4- 584
2,765 4- 1,301
869 4- 522
l 1,682 4- 1,669
2,755 ± 1,517
16,130 4- 2,149

3,172 ± 664
62,922 4-6,106
670 4- 800
18,509 ± 3,431
660 4- 359
16,461 4- 706

32,670 ± 1,243

13,073 4- 2,292

4,378 4- 2,875

2,732 4- 782

Syn
Allo
Syn
Allo
Syn
Allo
Syn
Allo
Syn
Allo
Syn
Allo
Syn
AIIo

11,621 4- 2,397
ND
14,943 4- 363
112,435 4- 5,571
5,474 ± 412
42,893 4- 4,891
999 + 185
15,032 4- 1,496
3,291 ± 1,088
31,280 ± 4,371
1,130 4- 443
17,138 + 4,393
1,334 4- 760
6,091 ± 483

8,489 4- 983
35,511 4- 4,882
7,403 4- 856
45,464 4- 2,787
1,562 ± 899
8,433 4- 461
641 ± 402
2,943 4- 1,042
1,981 4- 721
19,684 4- 552
611 ± 4 4 4
7,199 4- 3,143
2,124 4- 1,333
763 4- 103

5,858 4- 2,225
26,797 4- 3,999
7,222 4- 2,668
32,161 4- 7,375
677 4- 325
3,324 4- 1,258
422 ± 285
1,546 ± 348
1,268 + 566
9,317 4- 2,058
1,9174-1,159
445 4- 125
1,226 ± 1,106
275 ± 218

2,548 4- 1,688
18,322 4- 6,l 10
1,620 4- 285
23,330 4- 6,648
458 ± 326
2,188 4- 740
855 4- 627
1,514 4- 739
595 4- 33 I
5,008 4- 1,989
1,1664-1,130
492 4- 195
ND
ND

735 4- 353

1,795
I 1,642
882
9,992

4- 994
4- 1,722
4- 620
4- 1,553

Experiment 1: E~-rosetted T cells and irradiated stimulator cells were cultured in round-bottomed wells. [~H]Thymidine uptake without stimulators
was 600 4- 287 for Syn responders and 3228 4- 1746 for Allo responders. The DC-enriched fraction was 35% DC, 10% monocytes, and 55% small cells.
Experiment 2: Nylon T cells and irradiated stimulator cells were cultured in flat-bottomed wells. [3H]Thymidine uptake without stimulators was 638
4- 464 for Syn responders, and 245 ± 132 for Allo responders. The DC-enriched fraction was 23% DC, 24% monocytes, and 53% small cells.
* Not done.

weak or totally inactive as stimulators. We conclude that human DC are the most
potent stimulating cells for both allogeneic and syngeneic MLR. It is possible that all
other cell populations would be nonstimulatory if depleted of DC.
Accessory Cell Function in Oxidative Mitogenesis. Human T cells, modified with
periodate, will not proliferate unless irradiated accessory cells (not periodate modified)
are added (32). The accessory cell activity of our different cell populations paralleled
MLR-stimulating capacity in most experiments. Again, DC-enriched fractions were
the most active accessory cells, and this was not reduced by B cell depletion (Table
IV, experiment 2). Monocyte-enriched fractions varied in activity (compare experiments 1, 2, and 3, Table IV). In four out of five experiments, monocyte populations
were 10-30-fold less active than enriched DC. Monocytes did not inhibit DC when
co-cultivated, unless added at high doses (20%, see Table IV, experiment 3). B and T
cell fractions were again weak or inactive. We conclude that human DC, like rodent
DG (2, 9), are potent accessory cells for the proliferation of periodate-modified T cells.
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Experiment 1
DC enriched (without Ealg rosetting)
Mon~cyte enriched (firmly adhero
ent)
Monocyte enriched (readherent)

Dose of irradiated stimulator cells
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TABLE IV

Ability of Subpopulations of Mononuclear Cells to Act as Accesso(y Cellsfor Oxidative Mitogenesis
Accessory cell population
Experiment

l0 b

3 × 104

104

3 × 10a

68,297 ± 6,811

34,30l ± 1,890

13,796 ± 936

42,170 ± 27,057

46,162 ± 1,653

24,048 ± 1,958

51,470 ± 2,353

39,427 ± 4,290

18,285 ± 1,183

2,180 ± 571

2,228 ± 886

108,024 ± 2,625

ND*
15,384 ± 2,395

5,245 ± 1,219
5,146 ± 718

3,145 ± 718

Experiment 2

5 x 104

1.5 × 104

5 × 103

1.5 × 10a

DC enriched (with Ectla rosetting)
DC enriched (without EctIg rosetting)
Monocyte enriched (firmly adherent)
B cell enriched (with Et~Ig rosetting)
B cell enriched (without E~dg
rosetting)
T cell enriched (nylon wool T)

84,518 ± 9,624

69,385 ± 1,714

44,854 ± 1,522

25,335 ± 3,840

98,293 ± 8,348

66,560 ± 8,023

42,463 ± 1,091

27,402 ± 2,278

17,379 ± 2,385

8,485 ± 1,064

7,274 ± 840

4,961 ± 982

38,527 ± 6,498

18,831 ± 1,345

8,463 ± 1,603

5,809 ± 2,346

5,743 ± 1,493

3,757 ± 236

2,536 +_ 865

3,69l ± 1,162

7,801 ± 1,468

5,525 ± 1,215

3 × 104

104

3 × 10a

103

63,691 ± 3,224

39,013 ± 4,010

19,977 ± 4,457

10,985 --- 1,724

5,966 ± 754

7,317 ± 904

4,610 ± 1,150

3,237 ± 214

36,899 ± 754
19,438 ± 1,914

36,320 ± 904
8,815 ± 1,866

22,616 ± 1,150
5,218 ± 957

9,484 ± 214
3,735 ± 744

4,779 + 683

4,215 ± 683

Experiment 3
DC enriched (with Ealg rosetting)
Monocyte enriched (firmly adherent)
DC-monocyte mixture:~
B cell enriched (with EaIg rosetting)
T cell enriched (nylon wool T)

Experiment 1: F~-rosetted T cells (+IO4) and irradiated accessory cells were cultured in round-bottomed
wells, and the same populations used as M L R stimulators in Table III experiment 1 were used as irradiated
accessory cells. Proliferative response of T ceils only (no 104) was 177 ± 59; T cells only (+IO4) was 5,772
± 3,935; and T cells (no 104) + 105 DC enriched was 2,501 ± 380.
Experiment 2: Nylon T cells (+104) and irradiated accessory cells were cultured in fiat-bottomed wells.
T h e twice-released fraction (see Table I) was divided in half and treated with bovine E or bovine E antih u m a n Ig, and floated in BPA. This produced two DC-enriched fractions (low density) and two B cell
fractions (high density). T h e DC-enriched fraction with E anti-human Ig was 31% DC, 45% monocytes,
and 24% small cells. The DC-enriched fraction without E anti-human Ig was 28% DC, 34% monocytes,
and 38% small cells. Proliferative responses o f T cells only (no IO4) was 358 ± 157; T cells only (+ IO4)
3,418 ± 754; and for T cells (no IO4) + 5 × 104 DC was 3,856 ± 810.
Experiment 3: Nylon T cells (+IO4) and irradiated accessory cells were cultured in fiat-bottomed wells.
T h e DC-enriched fraction was 34% DC, 16% monocytes, and 50% small cells. Proliferative responses o f T
cells only (no IO4) was 2,584 + 485; T cells only (+IO4) was 2,648 _-. 737; and for T cells (no 104) + 3 ×
104 DC was 5, 231 ± 389.
* Not done.
:~ T h e DC-monoeyte mixture (1:1) had 6 × 104 total cells at the highest dose, 2 × 104 cells at the next
dose, etc.
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DC enriched (without Ectlg rosetting)
Monocyte enriched (firmly adherent)
Monocyte enriched (readherent)
B cell enriched (without Ealg
rosetting)
T cell enriched (En ÷)
Non-T ceils (En-)

Doses of irradiated accessory cells
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Discussion
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H u m a n blood mononuclear cells have a small subpopulation (0.1-0.5%) of DC that
are virtually identical to DC in mouse and rats. Human DC were enriched to 20-60%
purity and compared with enriched populations of monocytes, B cells, and T cells by
several criteria. First, the morphology of DC is distinctive. DC extend smooth
cytoplasmic processes in several directions, have irregularly shaped nuclei and many
mitochondria, but exhibit few lysosomes or endocytic vacuoles. Second, DC express
histocompatibility (HLA, HLA-DR) and leukocyte-common antigens, but lack the
principle differentiation markers of monocytes (phagocytic capacity, peroxidase,
esterase, Fc receptors, four surface antigens detected with monoclonal Ab), B cells
(surface and intracellular Ig), and T cells (E-rosette receptor; O K T 3, 6, and 8
antigens). Third, DC are at least 10 times more active than other cells as M L R
stimulators and as accessory cells for periodate-induced mitogenesis.
A clear difference between DC of man and mouse is that human DC express
complement receptors, i.e., they rosette erythrocytes coated with IgM and fresh mouse
serum. Complement receptors have not been detected on mouse DC with the same
reagent. Conceivably this difference is related to the species or tissue studied, the
possibility that the receptor in mouse may be masked or occupied by endogenous
complement, or the possibility that expression of complement receptors may be
associated with an activation or differentiation step.
This paper provides the first description of DC in the circulation. Circulating cells
are likely to be part of a widely spread DC system. For example, we have found DC
in human spleen and tonsil that are indistinguishable from blood DC in morphology,
low bouyant density, and surface markers. In mice and rats, DC have been enriched
from spleen and node (2-5) and can be detected in thymus, liver, and peritoneal
cavity (33 and R. Steinman, unpublished observations). Hart and Fabre have
visualized Ia-bearing DC in sections of all rat nonlymphoid tissues except brain (34).
Mason et al. (3) have demonstrated a substantial flux (>106 cells/d) of typical DC
into the afferent lymph draining rat intestine. These DC probably are identical to
Langerhans cells in the afferent lymph of guinea pigs (35) and "veiled" cells in
afferent lymph of rabbits (36). DC in all sites (lymph, lymphoid, and nonlymphoid
organs) are bone marrow derived, bear Ia and leukocyte-common antigen, and lack
the differentiation markers of macrophages and B cells (3, 5, 34, 37, 38).
Relatively little is known about the kinetics and sites of DC production and their
movement between different organs. Are all DC in tissues end-stage elements derived
from proliferating bone marrow precursors? Can DC recirculate from one compartment to another, or at least move continuously from tissues to lymphoid organs via
afferent lymph? Can DC proliferate locally in tissues, or be elicited from the marrow
in increased numbers during inflammatory responses? The behavior of DC in inflammation is an important unknown, since entry of such potent accessory cells into a
lesion would intensify immune responses at the local level. For example, cells resembling DC have been described in synovial tissue from patients with rheumatoid
arthritis (39, 40). In preliminary experiments on rheumatoid synovial exudates, we
have found relatively large numbers of cells that have the same cytologic features and
surface markers as blood DC.
There are difficulties with the study of DC from human blood compared with
mouse spleen. First, it is difficult to study DC in fresh, adherent blood mononuclear
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Summary
Previous studies demonstrated that lymphoid tissues of mice and rats contain small
numbers (<1% of nucleated cells) of dendritic cells (DC) with special cytologic,
surface, and functional properties. We show here that similar DC represent 0.1-0.5%
of human peripheral blood mononuclear cells. DC can be enriched to 20-60% purity
by a multistep procedure analogous to that used in mice. Adherent peripheral blood
mononuclear cells are cultured overnight, and the released cells are depleted of
monocytes and B cells by readherence to plastic, rosetting With erythrocytes coated
with anti-human IgG, and centrifugation in dense albumin columns. Enriched DC
have similar cytologic features to rodent DC by light and electron microscopy.
DC express HLA, and HLA-DR and the leukocyte-common antigens. They lack
phagocytic capacity, receptors for antibody-coated and neuraminidase-treated erythrocytes, surface and intracellular Ig, esterase, peroxidase, and azurophilic granules.
DC do not react with several monoclonal antibodies directed to phagocytes (OKM 1,
"mac-l," 63D3, and 61D3) and T cells (OKT 3, 6, 8). Unlike the mouse, human DC
express complement receptors. When maintained in culture for 4 d, human DC did
not give rise to either B cells or monocytes. Therefore, DC identified by cytologic
criteria are distinct from other leukocytes.
Enriched populations of DC have been compared to fractions enriched in monocytes, B cells, and T cells in three functional assays: stimulation of the primary
allogeneic mixed leukocyte reaction, stimulation of the primary syngeneic MLR, and
accessory function for the proliferation of periodate-modified T cells. In each case, the
DC fraction was 10-fold or more active than other cell fractions. We conclude that
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cells because they are far outnumbered by B cells and monocytes. In contrast, mouse
spleen adherent cells contain 10-50% DC. Second, human DC cannot be significantly
enriched by density gradient separation of fresh blood mononuclear cells, because
almost all monocytes are of low density as well. Mouse splenic DC are enriched by
this technique because most splenic macrophages are of high density. Third, human
DC cannot be enriched to the same degree of purity as mouse (>90%). The majority
of the contaminating cells a r e s m a l l , Ia-bearing cells, which lack differentiation
markers of B cells, T cells, and monocytes and do not differentate into these in culture.
We have assumed, because of analogy to the rat and mouse, that the cells with the
cytologic characteristics of DC account for the functional activity of DC-enriched
fractions, but small, Ia-bearing cells may also contribute. Fourth, it is more difficult
to deplete DC from human monocyte and lymphocyte fractions. Monocyte-enriched
fractions contained 1-6% DC, B cells enriched with anti-Ig rosetting contained 1-4%
DC, and non-T cells contained 2-10% DC. These levels of DC contamination could
account for the variable functional activity of these populations.
We propose that DC are the principal M L R stimulators and accessory cells in
human blood mononuclear cells, because DC fractions are much more potent than
other fractions and because the small numbers of DC in the other fractions could
explain their activity. Reagents that would selectively deplete human DC are needed
to pursue this hypothesis. In mouse, a DC-specific cytotoxic monoclonal Ab ablates
MLR-stimulating activity from mouse spleen (12). "It is hoped that the DC-enriched
populations described in this paper will be useful, as in the mouse, to immunize and
screen for human DC-specific monoclonal Ab.
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DC circulate in m a n , a n d represent the principal cell type required for the initiation
of several i m m u n e responses.
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